Table 3 Major clinical events after diagnosis and outcome in the study population (n = 382).
From: Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
Events | |
|---|---|
Major thrombosis, n (%) | 56 (15) |
Rate % pts/year, (95% CI) | 1.99 (1.53–2.60) |
Arterial, n (%) | 30 (8) |
Rate % pts/year, (95% CI) | 1.00 (0.70–1.45) |
Venous, n (%) | 28 (7) |
Rate % pts/year, (95% CI) | 0.95 (0.66–1.38) |
Major bleeding, n (%) | 28 (7) |
Rate % pts/year, (95% CI) | 0.94 (0.65–1.36) |
Overt MF, n (%) | 60 (16) |
Rate % pts/year, (95% CI) | 2.05 (1.59–2.64) |
AML, n (%) | 29 (8) |
Rate % pts/year, (95% CI) | 0.95 (0.66–1.36) |
Death, n (%) | 105 (27) |
Rate % pts/year, (95% CI) | 3.41 (2.81–4.13) |
